Understanding the biology of the disease to guide treatment choices

Predictors of response to mCRPC therapy: where do we stand?

Translational studies of CDK and PARP inhibitors

Preventing metastases by tackling exosomes

Moving breast cancer stem cell therapies to the clinic

PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy

Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy

Careers in translational research

New line of therapy for acute myeloid leukaemia

Role of Bcl-2 family in lymphoid malignancies

Chemo-free treatment for acute promyelocytic leukaemia

NeoALTTO trial indicates breast cancer patients who had pathologic complete response had improved event-free and overall survival